Oxford Nanopore Technologies company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Founded Year




Total Raised


Date of IPO


Market Cap


About Oxford Nanopore Technologies

Oxford Nanopore Technologies develops a nanopore DNA sequencer, the MinION. The MinION is a portable, real-time, long-read, low-cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or even microgravity biology.

Oxford Nanopore Technologies Headquarter Location

Gosling Building Edmund Halley Road, Oxford Science Park

Oxford, England, OX4 4DQ,

United Kingdom

+44 (0)845 034 7900

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Oxford Nanopore Technologies

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Oxford Nanopore Technologies in 7 CB Insights research briefs, most recently on Mar 29, 2022.

Expert Collections containing Oxford Nanopore Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Oxford Nanopore Technologies is included in 5 Expert Collections, including Medical Devices.


Medical Devices

8,546 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

3,095 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data


Digital Health

13,068 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

7,900 items

Oxford Nanopore Technologies Patents

Oxford Nanopore Technologies has filed 192 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • DNA
  • Biotechnology
patents chart

Application Date

Grant Date


Related Topics




Molecular biology, RNA, DNA, Biotechnology, Genetics


Application Date


Grant Date



Related Topics

Molecular biology, RNA, DNA, Biotechnology, Genetics



Latest Oxford Nanopore Technologies News

Long Read Sequencing Market Research Report by Technology, Product, Workflow, Application, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Jun 16, 2022

Product, Workflow, Application, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06256667/?utm_source=GNW The Global Long Read Sequencing Market size was estimated at USD 1,165.48 million in 2021 and expected to reach USD 1,460.69 million in 2022, and is projected to grow at a CAGR 25.50% to reach USD 4,555.27 million by 2027. Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period. Market Segmentation & Coverage: This research report categorizes the Long Read Sequencing to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Technology, the market was studied across Nanopore Sequencing and Single-Molecule Real-Time Sequencing. Based on Product, the market was studied across Consumables, Instruments, and Services. Based on Workflow, the market was studied across Data Analysis, Pre-sequencing, and Sequencing. Based on Application, the market was studied across Cancer, Identification & Fine Mapping Of Structural Variation, Pseudogene Discrimination, Reproductive Genomics, Resolving Allele Phasing, Tandem Repeat Sequencing, and Viral & Microbial Sequencing. Based on End-user, the market was studied across Academic Research, Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities. Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market. Cumulative Impact of 2022 Russia Ukraine Conflict: We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia. This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Long Read Sequencing market considering the current update on the conflict and its global response. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Long Read Sequencing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service. Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Long Read Sequencing Market, including 10x Genomics, Inc., BaseClear B.V., Bionano Genomics, Inc., Dovetail Genomics, LLC, F. Hoffmann-La Roche Ltd, Future Genomics Technologies B.V., Honeywell International Inc., Illumina, Inc., Intel Corporation, Keygene N.V., Longas Technologies, MicrobesNG, MyJoVE Corporation, Oxford Nanopore Technologies Limited, PerkinElmer Inc., Quantapore, Inc., Sage Science, Inc., Takara Bio USA Holdings, Inc., TATAA Biocenter, and Thermo Fisher Scientific Inc.. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Long Read Sequencing Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Long Read Sequencing Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Long Read Sequencing Market? 4. What is the competitive strategic window for opportunities in the Global Long Read Sequencing Market? 5. What are the technology trends and regulatory frameworks in the Global Long Read Sequencing Market? 6. What is the market share of the leading vendors in the Global Long Read Sequencing Market? 7. What modes and strategic moves are considered suitable for entering the Global Long Read Sequencing Market?

Oxford Nanopore Technologies Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Oxford Nanopore Technologies Rank

  • When was Oxford Nanopore Technologies founded?

    Oxford Nanopore Technologies was founded in 2005.

  • Where is Oxford Nanopore Technologies's headquarters?

    Oxford Nanopore Technologies's headquarters is located at Gosling Building, Oxford.

  • What is Oxford Nanopore Technologies's latest funding round?

    Oxford Nanopore Technologies's latest funding round is IPO.

  • How much did Oxford Nanopore Technologies raise?

    Oxford Nanopore Technologies raised a total of $1.179B.

  • Who are the investors of Oxford Nanopore Technologies?

    Investors of Oxford Nanopore Technologies include IP Group, Nikon, Temasek, M&G Investments, Wellington Management and 18 more.

  • Who are Oxford Nanopore Technologies's competitors?

    Competitors of Oxford Nanopore Technologies include Pacific Biosciences and 3 more.

You May Also Like

Xbio Systems

Xbio Systems has developed the Integrated Drug Development Platform (IDDP), a solution that supports drug and device development by combining process automation, content management and business intelligence capabilities on a secure, adaptable web platform.

Navican Genomics

Navican provides a personalized approach to testing, diagnosing, and treating cancer. The company's unique process analyzes the genetic makeup of a patient's cancer and employs a team of skilled molecular tumor specialists to review each test and determine how to most effectively treat that cancer case.

Tempus Logo

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.

American Biosystems

American Biosystems, Inc., produces and markets biological products used in Agriculture, Aquaculture and Industry. Specialized bacterial cultures are grown and harvested to produce enzymes ... nature's catalysts. These products can be incorporated into animal feed as a natural alternative to hormones and antibiotics while providing many of the same benefits. For Aquaculture, bacteria digest uneaten feed and waste products, providing cleaner water and producing less stress on farm-raised shrimp. For Industry, target markets include complex manufacturing processes, bio-medical cleaning products, waste reduction and recycling. Bacteria and the enzymes they produce are nature's way of breaking down wastes into harmless components or building blocks man can use to rebuild or remake other products. The company was founded in 1982 by Lewis E. Goyette, Ph.D, and is now managed by his son Edward M. Goyette. The company markets in over 15 countries through overseas distributors and currently has two employees in The New Century Venture Center. American Biosystems moved into the center on May 31, 2002.

Functional Biosciences

Functional Biosciences specializes in genomics research. The company produces reagents and an informatics tools, and aims to provide services that simplify preclinical drug development, reduce the costs of toxicity screening, improve the efficiency of DNA sequencing, and more.

Nabsys Logo

Nabsys develops semiconductor-based tools for genomic analysis that are capable of analyzing entire genomes in very large fragments.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.